Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margherita Fabbri

Showing results (1-10 of 146) with videos related to

Pageof 15
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|May 2, 2026
Neurology Under Fire: What About Parkinson's Disease in Wartime?Margherita Fabbri, Olivier Rascol
Neurology and Therapy|February 2, 2023
Correction to: Off-time Treatment Options for Parkinson's DiseaseMargherita Fabbri, Raquel Barbosa, Olivier Rascol
Neurology and Therapy|January 12, 2023
Off-time Treatment Options for Parkinson's DiseaseMargherita Fabbri, Raquel Barbosa, Olivier Rascol
Neurodegenerative Disease Management|March 22, 2021
Opicapone for Parkinson's disease: clinical evidence and future perspectivesClémence Leung, Olivier Rascol, Margherita Fabbri
The Lancet. Neurology|October 22, 2021
Amantadine in the treatment of Parkinson's disease and other movement disordersOlivier Rascol, Margherita Fabbri, Werner Poewe
CNS Drugs|February 26, 2022
COMT Inhibitors in the Management of Parkinson's DiseaseMargherita Fabbri, Joaquim J Ferreira, Olivier Rascol
Expert Opinion on Investigational Drugs|August 28, 2020
Therapeutic strategies for Parkinson's disease: promising agents in early clinical developmentMargherita Fabbri, Santiago Perez-Lloret, Olivier Rascol
Neurologic Clinics|April 4, 2025
Disease-Modifying Therapies in Parkinson's DiseaseMargherita Fabbri, Jean Christophe Corvol, Olivier Rascol
Movement Disorders Clinical Practice|September 2, 2025
Reply: "Improving the Study of Impulse Control Disorders in CSAI-Treated Parkinson's Disease: Methodological and Interdisciplinary Directions"Clément Desjardins, Paulo André Dias Bastos, Margherita Fabbri
Frontiers in Neurology|October 26, 2020
Non-pharmacological Treatment Challenges in Early Parkinson's Disease for Axial and Cognitive Symptoms: A Mini ReviewGabriella Sharpe, Antonella Macerollo, Margherita Fabbri, et al.
Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
Movement Disorders : Official Journal of the Movement Disorder Society|May 2, 2026
Neurology Under Fire: What About Parkinson's Disease in Wartime?Margherita Fabbri, Olivier Rascol
Neurology and Therapy|February 2, 2023
Correction to: Off-time Treatment Options for Parkinson's DiseaseMargherita Fabbri, Raquel Barbosa, Olivier Rascol
Neurology and Therapy|January 12, 2023
Off-time Treatment Options for Parkinson's DiseaseMargherita Fabbri, Raquel Barbosa, Olivier Rascol
Neurodegenerative Disease Management|March 22, 2021
Opicapone for Parkinson's disease: clinical evidence and future perspectivesClémence Leung, Olivier Rascol, Margherita Fabbri
The Lancet. Neurology|October 22, 2021
Amantadine in the treatment of Parkinson's disease and other movement disordersOlivier Rascol, Margherita Fabbri, Werner Poewe
CNS Drugs|February 26, 2022
COMT Inhibitors in the Management of Parkinson's DiseaseMargherita Fabbri, Joaquim J Ferreira, Olivier Rascol
Expert Opinion on Investigational Drugs|August 28, 2020
Therapeutic strategies for Parkinson's disease: promising agents in early clinical developmentMargherita Fabbri, Santiago Perez-Lloret, Olivier Rascol
Neurologic Clinics|April 4, 2025
Disease-Modifying Therapies in Parkinson's DiseaseMargherita Fabbri, Jean Christophe Corvol, Olivier Rascol
Movement Disorders Clinical Practice|September 2, 2025
Reply: "Improving the Study of Impulse Control Disorders in CSAI-Treated Parkinson's Disease: Methodological and Interdisciplinary Directions"Clément Desjardins, Paulo André Dias Bastos, Margherita Fabbri
Frontiers in Neurology|October 26, 2020
Non-pharmacological Treatment Challenges in Early Parkinson's Disease for Axial and Cognitive Symptoms: A Mini ReviewGabriella Sharpe, Antonella Macerollo, Margherita Fabbri, et al.
Pageof 15